Quingestanol

This classification denotes a norpregnadiene with the molecular formula C25H34O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1A635076CE, chemically known as 3-cyclopentyloxy-19-nor-3,5-pregnadien-20-in-17beta-ol but generally known as quingestanol, which bears US NIH Compound Identifier 25414. European Medicines Agency schedules Quingestanol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10216MIG. World Health Organization schedules quingestanol in its Anatomical Therapeutic Chemical (ATC) Classification. QUINGESTANOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule quingestanol under HS 29372300 and SITC 54153. As of Q4 2014, QUINGESTANOL remains the US FDA Preferred Term for this commodity. SMILES: OC1(C2(C(C3C(CC2)C2C(=CC3)C=C(OC3CCCC3)CC2)CC1)C)C#C.